Table 4.
Screening of commercially available amines with structures related to 1a, 1b and 2a.
| Name and CAS no. | Structures | MRSA | E. coli | P. aeruginosa | M. tuberculosis | HepG2 | HEK 293 | A549 | THP-1 |
|---|---|---|---|---|---|---|---|---|---|
|
Benzylamine 100-46-9 |
|
>100 | >100 | >100 | >100 | >100 | >100 | >100 | >100 |
|
Dicyclohexylamine 101-83-7 |
|
>100 | >100 | 12.5 | >100 | >100 | >100 | >100 | >100 |
|
Dibenzylamine 103-49-1 |
|
>100 | >100 | 12.5 | >100 | >100 | >100 | >100 | >100 |
|
Tribenzylamine 620-40-6 |
|
>100 | >100 | 6.5 | >100 | >100 | >100 | >100 | >100 |
|
2,2′-Bipyridine 366-18-7 |
|
>100 | >100 | >100 | 0.1 | 3 | 3 | >100 | 50 |